Big Pharma Using Mail-Order Pharmacies to Maintain High Prices

The United States has the dubious honor of paying the highest prescription drug costs in the world. Many healthcare economists attribute this to relatively lax cost regulation compared to other wealthy countries; however, a decade of insurers paying only for generic drugs when available and limiting drug choice in specific formularies has had little modulating effect. The most recent focus has been on the newer, very costly agents that have come to market. Targeted cancer therapies may be priced at $70,000-$115,000 per year, reformulated chemotherapeutics may also reach the six-figure level and the new hepatitis C therapies are major effective advances, but cost about $80,000 for a 12-week course. Unlike the above diseases, multiple sclerosis requires life-long treatment and the latest player, Plegridyis, is pegged at $62,000 per annum.

 

As opposed to being feted for prolonging life and easing suffering, the major pharmaceutical companies are being attacked for price gouging at the expense of the public. The industry has pushed back, citing that the 10% of healthcare dollars going to prescription drugs has been the same percentage since 1960. Moreover, they emphasize that drug development is long (10-15 years), rather inefficient as most formularies never get to market, and costly (about $1.3 billion). This investment in time and money is reflected in the final price of the medication. The arcana of drug pricing is beyond my pay grade, given the variables of the potential market, duration of therapy, efficacy of treatment, socioeconomics, and societal commitment to equitable healthcare. A simple, transparent and fair pricing system may be more utopian than feasible and the politics of effecting change is a maelstrom of special interests.

 

However, there is one villain trying to sidestep the barriers on pricing whom I find particularly reprehensible. Several small pharmaceutical manufacturers circumvent restraints by insurers and pharmacists to switch patients to generics by promoting mail-order pharmacies affiliated with the drug company. The high-priced drugs are delivered quickly and copays are subsidized and because some insurers will pay the often exorbitant charges, the scheme is economically viable. Here are examples-- Horizon Pharma has a pain reliever, Duexis, which contains two generic equivalents of Motrin and Pepcid. It is targeted to patients as offsetting the gastrointestinal side effects of the NSAID.  Daily Duexis therapy costs about $1500/month, while the two drugs sold separately cost $20-$40/month as generics or OTC. The company says that combining the drugs into a single pill taken three times daily makes compliance more likely as patients will get the benefit of stomach protection. Valeant Pharmaceuticals does much the same thing for its dermatology products with its specialty pharmacy Philidor Rx Services

 

This is sophistry at its finest. Fortunately these attempts of dampening the sticker shock of using these drugs have caused many benefit managers to refuse all payment for these products. Moreover, these companies have also received subpoenas from federal prosecutors in New York and Massachusetts seeking more information on their pricing practices. Of more immediate harm, investors have seen the light as Valeant’s market capitalization has decreased 70% since August. This all begs the question: who writes these prescriptions and why? We do, and I cannot think why.

 

By Norman Silverman, MD, with Ryan McKennon, DO and Ren Carlton

 

Make Angel Investments That Go 10x, Unleashing Monster Returns for a Family Juice Business

I look for angel investments that have the potential to produce a 10x return on my investment in 5 years. Startup investing is one of the more risky investment categories. Therefore, you should expect these businesses to have the possibility of doing well. If you invest in 10 businesses, and nine of them fail, the remaining business needs to give you a 10x return just to break even. Ideally, you will do better than that and enjoy healthy returns.

Build Your List of Potential Investors, Pitch Investors Properly, How Kevin Systrom Raised $500,000 in Two Weeks to Launch InstagramFind Angel Funding & Venture Capital for Business Startups, Entrepreneurs, & First Time Founders – Episode 12

Most startups need funding at some point. Once you have the addressed all of the items in the previous episodes, it is time to build your list of potential investors and start the conversations. They can be friends, family, social network, social media contacts, work colleagues, people in the business industry, etc. Try to put together a list of at least one hundred people. A list of one hundred potential investors may seems like a lot, but the more people you have on the list, the better your chances are of success.

Making Money With Your Business, Profit and Cash Flow, Five Sustainable Companies That Make a Lot of MoneyFind Angel Funding & Venture Capital for Business Startups, Entrepreneurs, & First Time Founders – Episode 10

It is time to make money! You have been through a couple of rounds of market testing now you feel like you are on to something. The next step is to run the numbers to make sure that the business is sustainable. There are two sides to making money, profitability and cash flow.

Why Competition Is Good For Entrepreneurs and How Blockbuster’s $50 Million Mistake Helped Reed Hastings and Netflix Destroy a $6 Billion Empire Find Angel Funding & Venture Capital for Business Startups, Entrepreneurs, & First Time Founders – Epis

When battling for resources or investment, early-stage entrepreneurs may believe that competition is a bad thing. On the surface, they are correct. There are a limited number of angel investors willing to provide a finite amount of venture capital to founders.

Upscaling and Scaling Business Ideas into Reality – Jeff Bezos takes Amazon from Online Bookstore to Global DominanceFind Angel Funding & Venture Capital for Business Startups, Entrepreneurs, & First Time Founders – Episode 4

Congratulations, your market testing worked and you were able to find customers, or at least one customer. Your beta test was successful and you are confident that you are ready for more. What do you do when you start getting customers or users? I recommend you do some scaling or upscaling.

What Kind of Business Should You Start? – How Mark Zuckerberg Pivoted From Rating Hotness to FacebookFind Angel Funding & Venture Capital for Business Startups, Entrepreneurs, & First Time Founders – Episode 1

When it comes to brainstorming startup ideas, new entrepreneurs and even seasoned ones scratch their heads in confusion. Living in the information age, you can scan the current market and see countless new business ideas. With so many options out there, how do you know which one is right for you?

Why Would a Doctor Abandon a Steady Paycheck to Become an Entrepreneur?

As physicians, we are expected to be compliant with rules, restrictions, and regulations. We are expected to be risk averse. We are expected to be “providers,” but not necessarily innovators or leaders. As the healthcare system becomes increasingly consolidated into large overcrowded clinics, we are required to perform to the standards set by bureaucrats and clinic managers. These rules are often at odds with the best interests of patients and with our sanity.
Page: 1234 - All